Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor
NCT03129945 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2021-11-05
Summary
The purpose of this research study is to determine the best medication to stop preterm labor. Recent studies have identify nifedipine and indomethacin as the two medications that are most likely to delay delivery for 48 hours, decrease maternal side effects and decrease some complications related to preterm delivery to the neonate. Both of these medications are commonly used to stop pre-term labor, therefore it has become our institution's standard to use these two medications in the setting of preterm labor. There have been limited studies comparing these two medications directly.
A total of 450 participants will be asked to participate across all study sites.
Conditions
- Obstetric Labor, Premature
Interventions
- DRUG
-
Nifedipine
Subjects will be given nifedipine 10mg orally and repeated every 20 minutes for a maximum dose of 30mg in the first hour followed by 20mg every 6 hours for the first 48 hours.
- DRUG
-
Indomethacin
Those randomized to indomethacin will be given 100mg orally as a loading dose followed by 50mg every 6 hours for the first 48 hours of treatment.
Sponsors & Collaborators
-
University of California, San Francisco
collaborator OTHER -
University of California, Davis
collaborator OTHER -
University of California, San Diego
collaborator OTHER -
University of California, Los Angeles
collaborator OTHER -
University of California, Irvine
lead OTHER
Principal Investigators
-
Deborah A Wing, MD · University of California, Irvine
-
Mary Norton, MD · University of California, San Francisco
-
Gladys (Sandy) Ramos, MD · University of California, San Diego
-
Aisling Murphy, MD · University of California, Los Angeles
-
Veronique Tache, MD · University of California, Davis
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-17
- Primary Completion
- 2019-04-18
- Completion
- 2019-04-18
Countries
- United States
Study Locations
More Related Trials
-
Individualized Dosing of Nifedipine For Tocolysis in Preterm Labor
NCT02090920 ·Status: COMPLETED
-
Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery
NCT00525486 ·Status: TERMINATED ·Phase: NA
-
Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor
NCT00306462 ·Status: TERMINATED ·Phase: NA
-
Vaginal Indomethacin for Preterm Labor
NCT04404686 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Nifedipine Pharmacokinetics and Pharmacodynamics When Used as a Tocolytic in Acute Threatened Preterm Labour
NCT02068404 ·Status: UNKNOWN ·Phase: PHASE4
-
Two Dose Regimens of Nifedipine for the Management of Preterm Labor
NCT00137501 ·Status: TERMINATED ·Phase: PHASE3
-
Magnesium Sulfate Versus Nifedipine for the Acute Tocolysis of Preterm Labor: A Prospective, Randomized Trial
NCT00185900 ·Status: COMPLETED ·Phase: NA
-
Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
NCT00185952 ·Status: COMPLETED ·Phase: NA
-
Nifedipine Treatment in Preterm Labor
NCT01314859 ·Status: WITHDRAWN ·Phase: PHASE3
-
Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population
NCT00641784 ·Status: TERMINATED ·Phase: PHASE3
-
Nifedipine Compared to Atosiban for Treating Preterm Labor
NCT00599898 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study Between Nifedipine and Ritodrine as Maintenance Tocolytic Therapy in Preterm Labor
NCT03040752 ·Status: COMPLETED ·Phase: PHASE4
-
Management of Acute Preterm Labor: Nifedipen Alone or Combined With Cildenafil Citrate
NCT02337881 ·Status: UNKNOWN ·Phase: PHASE1
-
Tocolysis for Preterm Labor
NCT00811057 ·Status: COMPLETED ·Phase: NA
-
Tocolysis in Prevention of Preterm Labor
NCT03298191 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparative Study Between Nicorandil and Nifedipine for the Treatment of Preterm Labour
NCT04846621 ·Status: UNKNOWN ·Phase: PHASE2
-
Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor
NCT04392375 ·Status: COMPLETED ·Phase: PHASE4
-
Utility of Tocolytic Therapy for Maintenance Tocolysis in the Management of Threatened Preterm Delivery
NCT01796522 ·Status: WITHDRAWN ·Phase: PHASE3
-
Nifedipine Plus Magnesium Sulfate Versus Magnesium Sulfate for Very Early Preterm Tocolysifs
NCT05345132 ·Status: RECRUITING ·Phase: NA
-
The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor
NCT00404768 ·Status: COMPLETED ·Phase: PHASE2
-
Nifedipine Versus Magnesium Sulfate for Late Preterm Tocolysis
NCT05343806 ·Status: COMPLETED ·Phase: NA
-
Fetal Cardiac Effects of Tocolytic Nifedipine and Magnesium Sulfate
NCT06904534 ·Status: ACTIVE_NOT_RECRUITING
-
Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth
NCT02913495 ·Status: COMPLETED ·Phase: PHASE4
-
Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation
NCT03976063 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Transdermal Nitroglycerin and Nifedipine in Preterm Labor
NCT02583633 ·Status: COMPLETED ·Phase: PHASE4